Pathogenetix Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pathogenetix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011332
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence scanning technology to detects bio-threat pathogens in environmental samples. It offers microbial genotyping system including targeted assays, benchtop instrument, and onboard bioinformatics. Pathogenetix’s bench top instrument integrates various components including genome classifier for automated data analysis, genome processor for DNA sample preparation, and genome scanner for stretching and scanning of DNA fragments, assay kits including salmonella and E.coli assay. The company also provides resolution system including benchtop instrument, targeted assays, and onboard bioinformatics. It serves food safety testing, industrial microbiology, clinical diagnostics and research markets. Pathogenetix is headquartered in Watertown, Massachusetts, the US.

Pathogenetix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pathogenetix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pathogenetix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pathogenetix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pathogenetix Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pathogenetix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pathogenetix Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Pathogenetix Raises US$10 Million In Series C Financing 10
Pathogenetix Raises US$3.6 Million In Venture Financing 11
Pathogenetix Secures Additional US$7.5 Million In Series B Financing 12
Partnerships 13
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 13
Pathogenetix Enters Into Co-Development Agreement With Sagentia 14
Asset Transactions 15
Toxic Reports Acquires RESOLUTION Microbial Genotyping System from PathoGenetix 15
Pathogenetix Inc – Key Competitors 16
Pathogenetix Inc – Key Employees 17
Pathogenetix Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pathogenetix Inc, Medical Equipment, Key Facts 2
Pathogenetix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pathogenetix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pathogenetix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pathogenetix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pathogenetix Inc, Deals By Market, 2011 to YTD 2017 8
Pathogenetix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pathogenetix Raises US$10 Million In Series C Financing 10
Pathogenetix Raises US$3.6 Million In Venture Financing 11
Pathogenetix Secures Additional US$7.5 Million In Series B Financing 12
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 13
Pathogenetix Enters Into Co-Development Agreement With Sagentia 14
Toxic Reports Acquires RESOLUTION Microbial Genotyping System from PathoGenetix 15
Pathogenetix Inc, Key Competitors 16
Pathogenetix Inc, Key Employees 17

★海外企業調査レポート[Pathogenetix Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ambuja Cements Limited:企業の戦略・SWOT・財務分析
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Abbott Point of Care Inc:企業の製品パイプライン分析2018
    Summary Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its p …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pharmacosmos AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Saudi Electricity Co:発電所・企業SWOT分析
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • 7C Solarparken AG (HRPK):企業の財務・戦略的SWOT分析
    Summary 7C Solarparken AG (7C Solarparken), formerly Colexon Energy AG is a renewable energy company that develops and operates photovoltaic farms. The company operates, maintains, and administrates the photovoltaic power plants with acquisition, financing and optimization of operating assets. Its d …
  • The Hartz Mountain Corporation:企業の戦略・SWOT・財務分析
    The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report Summary The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AGL Energy Limited:企業の戦略・SWOT・財務分析
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sangoma Technologies Corporation (STC):企業の財務・戦略的SWOT分析
    Sangoma Technologies Corporation (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務分析
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Otto GmbH & Co KG:企業の戦略・SWOT・財務情報
    Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • aTyr Pharma Inc (LIFE)-製薬・医療分野:企業M&A・提携分析
    Summary aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class o …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆